Tag
BioNTech SE
2 articles
BioNTech Shares Drop 10% After Trial Halt
BioNTech SE stock fell about 10% on Friday after it announced termination of its Phase 2 colorectal cancer mRNA vaccine trial (BNT122‑01).
The Genentech‑co‑developed trial was halted for futility afte
BioNTech Shares Drop 10% After Trial Termination
BioNTech SE's shares fell about 10% on Friday after it announced termination of its Phase 2 colorectal cancer mRNA immunotherapy trial (BNT122‑01).
The independent Data Safety Monitoring Board recomme